De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC

Clinical trial NCT06692725 · RECRUITING

Trial details

NCT number: NCT06692725
Sponsor: Peking University People's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Triple Negative Breast Cancer

Start date: 2019-01-01
Primary completion: 2028-12-31
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.